Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

BackgroundSquamous cell carcinoma (SCC) is one of the most common subtypes of non-small cell lung cancer, but its treatment options remain limited. Epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors (TKIs) have limited efficacy in the treatment of lung SCC. Here, we report an SCC pat...

Full description

Bibliographic Details
Main Authors:	Zhiqin Zhang, Jiamao Lin, Linke Yang, Yang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Oncology
Subjects:	non-small cell lung carcinoma squamous cell carcinoma EGFR mutation targeted therapy cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1188772/full

Similar Items

Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with <i>EGFR</i> Gene Mutation–Case Report and a Literature Review
by: Anna Rekowska, et al.
Published: (2022-05-01)

Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review
by: Chihiro Maeda, et al.
Published: (2023-10-01)

Association of PD‐L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR‐mutated NSCLC
by: Yusuke Hamakawa, et al.
Published: (2023-09-01)

An epidermal growth factor receptor-mutated lung adenocarcinoma patient with brain lesions resisted to osimertinib monotherapy but achieved more than 4 years of survival in osimertinib plus bevacizumab metronomic treatment
by: Jie Liu, et al.
Published: (2024-01-01)

Synchronous lung cancer presenting with small cell carcinoma and squamous cell lung carcinoma: a case report
by: Emanuele Stirpe, et al.
Published: (2023-09-01)

Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report
by: Wang D, et al.
Published: (2023-08-01)

Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma
by: Tadashi Nishimura, et al.
Published: (2023-03-01)

Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
by: Soei Gen, et al.
Published: (2022-06-01)

Whole-Exome Sequencing Could Distinguish Primary Pulmonary Squamous Cell Carcinoma From Lung Metastases in Individuals With Cervical Squamous Cell Carcinoma
by: Lihong Li, et al.
Published: (2022-05-01)

Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma
by: Liu Y, et al.
Published: (2023-02-01)

The changing anatomic position of squamous cell carcinoma of the lung – a new conundrum
by: William Krimsky, et al.
Published: (2016-12-01)

Differences of inflammatory microenvironment and sensitive correlation to cisplatin-chemotherapy in lung adenocarcinoma and squamous cell carcinoma
by: Zhilei Cui, et al.
Published: (2022-10-01)

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
by: Agnieszka Rybarczyk-Kasiuchnicz, et al.
Published: (2021-01-01)

Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation
by: Duen-Yi Huang, et al.
Published: (2020-02-01)

A visualized dynamic prediction model for overall survival in patients diagnosed with brain metastases from lung squamous cell carcinoma
by: Min Liang, et al.
Published: (2023-06-01)

A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma
by: Wu G, et al.
Published: (2022-04-01)

EGFR Mutation in Nasopharyngeal Carcinoma
by: Evren Uzun, et al.
Published: (2022-10-01)

Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
by: Chen-ye Shao, et al.
Published: (2023-09-01)

Prevalence of Lung Cancer in Al Najaf Governorate Registered in Middle Euphrates Oncology Center during 2019 and 2020
by: Zahraa Al-Khateeb, et al.
Published: (2022-04-01)

TP53 Mutations in Esophageal Squamous Cell Carcinoma
by: Leqi Zhong, et al.
Published: (2023-09-01)

Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma
by: Marko Tarle, et al.
Published: (2023-03-01)

Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer
by: Miguel A. Ortega, et al.
Published: (2023-01-01)

Durable clinical response to immunotherapy in EGFR-mutated lung adenocarcinoma with squamous cell carcinoma transformation and high expression of PD-L1 after resistance development: A case report
by: Zhongsheng Peng, et al.
Published: (2022-12-01)

Prognostic Significance of Glycolysis-Related Genes in Lung Squamous Cell Carcinoma
by: Sultan F. Kadasah
Published: (2024-01-01)

Segmentectomy for clinically early‐stage primary squamous cell carcinoma of the lung
by: Atsushi Kagimoto, et al.
Published: (2022-12-01)

Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer
by: Yufeng Li, et al.
Published: (2023-04-01)

Extra-Anogenital Giant Cutaneous Squamous Cell Carcinomas
by: Mateusz K. Mateuszczyk, et al.
Published: (2024-03-01)

Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma
by: Sarmad Al-Marsoummi, et al.
Published: (2020-09-01)

Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma
by: Qi Wang, et al.
Published: (2022-07-01)

The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung
by: Inmaculada Galindo, et al.
Published: (2020-01-01)

Detection of EGFR gene polymorphisms in non-small cell lung cancer Egyptian patients: a case–control study
by: Omali Y. El-khawaga, et al.
Published: (2023-11-01)

A Rare Case of Primary Cutaneous Basaloid Squamous Cell Carcinoma of the Finger
by: Ho Sung Kim, et al.
Published: (2024-02-01)

Synchronous pulmonary MALT lymphoma and squamous cell lung cancer: a case report
by: Zixin Guo, et al.
Published: (2023-06-01)

Incidence of Concomitant Neoplastic Diseases, Tumor Characteristics, and the Survival of Patients with Lung Adenocarcinoma or Squamous Cell Lung Carcinoma in Tobacco Smokers and Non-Smokers—10-Year Retrospective Single-Centre Cohort Study
by: Błażej Ochman, et al.
Published: (2023-03-01)

CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells
by: Shufeng Zhou, et al.
Published: (2022-07-01)

Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines
by: Gennaro Altamura, et al.
Published: (2022-11-01)

Lung cancer at a university hospital in Saudi Arabia: A four-year prospective study of clinical, pathological, radiological, bronchoscopic, and biochemical parameters
by: Alamoudi Omer
Published: (2010-01-01)

Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
by: Bhamini Patel, et al.
Published: (2021-07-01)

Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma
by: Anders Näsman, et al.
Published: (2021-05-01)

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
by: Akihiro Yoshimura, et al.
Published: (2019-03-01)